Sequans Exits Bitcoin, Enters the Prove-It Phase

With $40 million in cash and no debt, the micro-cap chipmaker must convert a $300 million design-win pipeline — and a $75 million licensing tease — into margin.

SQNS · Earnings Call · 2026-11-03

The clean balance sheet is the headline

For two years, Sequans was an IoT chipmaker with a Bitcoin treasury strategy strapped to it. That chapter is now closed. The company sold its last 314 Bitcoin at an average of roughly $78,500, raising $24.6 million, after redeeming its convertible debt in May. Cash and short-term deposits ended September at $39.8 million, and a $2.5 million Chengdu payment arrived in October. The only debt left is government R&D funding carried at $5.2 million, of which management expects to repay about $3 million over five years. Against a $42.8 million market capitalization, that leaves the operating business — a $9 million-per-quarter IoT semiconductor franchise — valued at close to zero by the public market.

As announced on September 24, we sold the remaining 314 Bitcoin held on our balance sheet as of June 30, completing the Bitcoin treasury exit that began with the full redemption of our convertible debt in May. These final sales were executed at an average price of approximately $78,500 per Bitcoin, for total proceeds of $24.6 million.
Georges Karam, CEO and Chairman · 2026-11-03

This was not the plan six months ago. On the August call, Georges Karam described liquidation as opportunistic: “The most logical way is to turn this to cash as soon as possible... we don't need really the cash immediately” — Georges Karam, Chief Executive Officer and Chairman · 2026-08-04. The Bitcoin treasury exit is now complete, and the stock is no longer a proxy for Bitcoin volatility. That is a genuine change in the investment case.

Product revenue is inflecting; the pipeline is still a three-year average

Q3 revenue was $9.1 million, up 22% sequentially and 183% year over year. Product sales more than quadrupled. Gross margin improved to 33% from 25.3% a year ago, operating expenses fell 25% to $10.3 million, and net loss narrowed to $1.5 million. Through nine months, revenue of $22.6 million already exceeds all of 2025’s $18.3 million, excluding $8 million of non-recurring Qualcomm revenue. The operating momentum is real: book-to-bill was above one for a third consecutive quarter, backlog extends into the second half of 2027, and the design-win pipeline stands at $300 million, with $165 million now in mass production. Management expects that mass-production portion to exceed $180 million by year-end. On the Q&A, Karam framed the math: “this represents three years' revenue... average for the three years, you have $60 million” — Georges Karam, CEO and Chairman · 2026-11-03. That is the bull case in one sentence — a $60 million average annual product run-rate versus roughly $36 million annualized in Q4 guidance. But the same $300 million pipeline has been the anchor for several quarters. The conversion from 44% in production at the start of the year to 55% by June is progress, not a step change. And the Q4 guide of $9.5 million to $11 million assumes limited licensing; the high end needs deals that have not yet signed.

RF, drones and licensing: the second leg is forming, slowly

The most interesting new growth vector is the Iris RF transceiver. It has generated more than 20 leads, a pipeline management pegs at over $30 million of three-year revenue potential, and the first drone customer is ready for production. “The first drone customer we announced last quarter is now ready for production, and we expect shipments to begin in Q4.” — Georges Karam, CEO and Chairman · 2026-11-03 In August, Karam said this could scale to “$10 million, $20 million per year with a margin closer to 90% plus.” — Georges Karam, Chief Executive Officer and Chairman · 2026-08-04 The drone business is no longer just a slide; it is a small order. But it is still small. Licensing is the recurring carrot. The pipeline exceeds $75 million, with individual deals from several hundred thousand dollars to more than $10 million. Management aims to close some in Q4 but deliberately excluded major deals from guidance, and even a signed deal may produce zero Q4 revenue due to recognition timing. This theme has been telegraphed since at least Q1, when Karam hoped to close something in Q2, and Q2, when he described a handful of advanced discussions for the second half. It has not yet converted. That is a credibility watch item. The 5G RedCap roadmap remains a 2028 story: test chip in-house, lab testing late this year, customer engagement in the second half of 2027, revenue in 2028. Management argues the transition will bring higher ASPs and less Chinese competition. Plausible, but not relevant to the next four quarters.

The margin hostage

The near-term risk is gross margin. Q4 is guided to be similar to Q3, and the culprit is memory. “we have a big, big problem with those memory that the price change every month, really every month, literally.” — Georges Karam, CEO and Chairman · 2026-11-03 The company is passing through costs where it can, but there is a lag. Double-sourcing of flash memory helps more in 2027 than in Q4. TSMC’s mature-node allocation in 2027 is another constraint; management says it has secured the majority of wafer needs but is still working on the rest. This is why the breakeven language has softened. In August, the target was “next year in a position very close to breakeven, if not breakeven on a yearly basis globally.” — Georges Karam, Chief Executive Officer and Chairman · 2026-08-04 On this call, the goal is "reaching break-even as quickly as possible" and "toward the break-even runway." That is not a promise broken, but it is a hedge. With $40 million of cash, the company can afford patience. The market, at a near-zero enterprise value, is not paying for it yet.

What the tape would tell us — if we had it

The price-tape context is blank for Sequans, so we cannot judge whether this report lands into accumulation or distribution. What we can say is that the balance-sheet transformation is complete, product revenue is growing, and the pipeline is large enough to matter. The missing piece is conversion at healthy margins. Until licensing lands or RF/drone becomes material, the stock is a cash pile with a call option on a $180 million mass-production pipeline. That is an unusual setup for a $43 million company — and a fair description of the prove-it phase.